PRTG Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Portage Biotech Inc - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Wall Street
Price Targets

PRTG Price Targets Summary
Portage Biotech Inc

There are no price targets for PRTG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Portage Biotech Inc Competitors:
Price Targets
301301
Yili Chuanning Biotechnology Co Ltd
2% Downside
INSM
Insmed Inc
20% Upside
GNS
Genus PLC
38% Upside
002252
Shanghai RAAS Blood Products Co Ltd
9% Upside
FOLD
Amicus Therapeutics Inc
60% Upside
DMAC
DiaMedica Therapeutics Inc
77% Upside
BEAM
Beam Therapeutics Inc
97% Upside
LEGN
Legend Biotech Corp
67% Upside

Revenue
Forecast

Revenue Estimate
Portage Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Portage Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Portage Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRTG's stock price target?
Not Available

PRTG doesn't have any price targets made by Wall Street professionals.

Back to Top